Go to main contentsGo to search barGo to main menu
Sunday, July 13, 2025 at 5:04 AM

NOTICE OF PUBLIC HEARING

NOTICE OF PUBLIC HEARING

 

NOTICE IS HEREBY GIVEN that a public hearing will be held in the Churchill County Administrative Complex, 155 North Taylor Street, County Commission Chambers, Fallon, Nevada:

 

On Wednesday, February 14, 2024, beginning at 7:00 p.m. the Churchill County Planning Commission will hold a public hearing on the following. An application for a zone change filed by Jared Card and Jesus Mariezcurrena for multiple properties located at the intersection of Carson Highway and Beasley Drive, Assessor Parcel Numbers 007-171-52, 007-171-53, 007-171-54, and 007-171-74, consisting of 4.26 acres in the C-1 zoning district. The applicant is requesting a zone change for the parcels from Commercial (C-1) to Industrial (I). Churchill County is also including the two remaining C-1 zoned adjacent properties in this request; the first being Assessor Parcel Number 007-171-56, owned by Galen and Margaret Hines, totaling approximately 0.49 acres; and the second being the portion of US 50 passing through or adjacent to the affected properties. Such consideration may include changing the zoning district to one that allows a less intensive range of uses.

 

If you cannot attend the Churchill County Planning Commission meeting, written comments may be submitted to the Public Works, Planning & Zoning Department, 155 N Taylor Street, Suite 194, Fallon, NV 89406, before 4:00 p.m., February 13, 2024. A copy of the application is on file and available for public inspection at the Churchill County Public Works, Planning & Zoning Department. A scanned copy of the application has also been published with the Planning Commission’s agenda on our web page at www.churchillcountynv.gov under Agendas & Minutes. The Planning Commission’s decision will be forwarded to the Churchill County Board of County Commissioners’ meeting to be held on March 7, 2024.

 

Dated at Fallon, Churchill County, Nevada, 2/1/24.

 

By: 

Loreli LeBaron       

 

Published in The Fallon Post online on February 2, 2024 and in print February 9, 2024.

Ad #6166


Share
Rate

Comment

Comments

COMMENTS
Comment author: Mike HinzComment text: I knew Sam as a member of our church growing up. He always had a warm smile, a kind word, and a great sense of humor! He will be great missed!Comment publication date: 7/2/25, 11:57 AMComment source: Obituary -- Samuel Bruce WickizerComment author: Mike HinzComment text: Great teacher, great coach, but even a better person!!! Rest in peace Mr. BeachComment publication date: 7/2/25, 11:53 AMComment source: Obituary -- Jack Victor Beach, Jr.Comment author: Mike HinzComment text: I had Mrs Hedges for First Grade at Northside Elementary in 1969. I still, to this day, remember her as a wonderful teacher…one of my favorites!!Comment publication date: 7/2/25, 11:29 AMComment source: Obituary - Nancy Marie Hedges C Comment author: Carl C. HagenComment text: What are MFNs and PBMs ?? ............................ From the editor: This is a very good question and we apologize for not catching that wasn't in there. We reached out to the writer/submitter and got this info back...hope it's helpful. PBM: Pharmacy Benefit Managers are pharmacies that are owned by insurance companies. (CVS is one.) They negotiate with drug makers to get reduced pricing for medications, but they historically have not passed along those savings to patients. https://www.ftc.gov/system/files/ftc_gov/pdf/pharmacy-benefit-managers-staff-report.pdf MFN: Most Favored Nation pricing is a policy that means a country agrees to offer the same trade concessions (like tariffs or price reductions) to all member nations of the World Trade Organization (WTO). When applied to pharmaceuticals, it could disrupt global access, deter innovation, and obscure the deeper systemic issues in American health care. https://petrieflom.law.harvard.edu/2025/05/22/the-global-risks-of-americas-most-favored-nation-drug-pricing-policy/Comment publication date: 6/23/25, 7:47 AMComment source: L E T T E R TO THE EDITOR
SUPPORT OUR WORK